To the full analysis
Arkema stock: growth
AKE.PAArkema reported $10.09B in revenue for fiscal 2025, down 5% on the prior year, up 2.8% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
2.5%
per year from 2006 to 2025, per share 1.7%
Earnings (Annual rate)
1.6%
per year from 2006 to 2025, per share 0.8%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.8% | 1.7% | 2.5% |
| Revenue per share | 3.1% | 1.4% | 1.7% |
| Earnings | −28.3% | −14.0% | 1.6% |
| Earnings per share | −26.9% | −14.3% | 0.8% |
| Free cash flow | −8.0% | −0.8% | no data |
| Free cash flow per share | −7.7% | −1.0% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $6.3B | $52.3M | −$304.88M |
| 2007 | $6.31B | $137.97M | $354.95M |
| 2008 | $6.27B | $111.27M | −$20.03M |
| 2009 | $4.94B | −$191.38M | $116.83M |
| 2010 | $6.57B | $386.11M | $218.09M |
| 2011 | $6.56B | −$21.14M | −$512.95M |
| 2012 | $7.12B | $244.79M | $16.69M |
| 2013 | $6.79B | $186.93M | −$15.58M |
| 2014 | $6.62B | $185.82M | $23.37M |
| 2015 | $8.55B | $317.12M | $406.14M |
| 2016 | $8.38B | $475.12M | $377.21M |
| 2017 | $9.26B | $640.92M | $610.87M |
| 2018 | $9.81B | $786.68M | $487.36M |
| 2019 | $9.72B | $604.2M | $711.02M |
| 2020 | $8.77B | $369.42M | $567.48M |
| 2021 | $10.59B | $1.46B | $169.13M |
| 2022 | $12.85B | $1.07B | $852.33M |
| 2023 | $10.59B | $447.31M | $692.1M |
| 2024 | $10.62B | $393.9M | $392.78M |
| 2025 | $10.09B | $70.1M | $374.98M |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 12 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.